Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, Mesco Pharmaceuticals has informed about submission of certificate received from its Registrar and Transfer Agent (RTA), Skyline Financial Services, confirming the dematerialization of share certificates for the quarter ended 31st March, 2020.
The above information is a part of company's filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1869.50 |
| Dr. Reddys Labs. | 1337.40 |
| Cipla | 1457.50 |
| Zydus Lifesciences | 1108.85 |
| Lupin | 2396.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: